News Focus

November 2008
Pharmaceutical Representative;Nov2008, Vol. 38 Issue 11, p10
The article offers news briefs related to the pharmaceutical industry in the U.S. Schering-Plough has contracted its sales force as part of its cost-cutting productivity production program with the said downsizing announced in April 2008. UCB Inc. has made an announcement concerning the launching of the Shaping Health as Partners in Education (SHAPE) program.


Related Articles

  • Wyeth, Schering-Plough scale down.  // Pharmaceutical Representative;Jun2008, Vol. 38 Issue 6, p10 

    The article offers news briefs related to the pharmaceutical industry in New Jersey. Wyeth plans to reduce about 6% of its workforce by the end of 2008 as part of its strategic program called Project Impact. Schering-Plough Corp. aims to save $1.5 billion per year in its productivity...

  • Cuts by Company.  // Pharmaceutical Executive;Sep2007, Vol. 27 Issue 9, p158 

    A list of U.S. pharmaceutical companies which made retrenchment in their employees in 2007. One of these companies is Pfizer Inc. with total job cuts of 10,000, with percentage workforce of 10% and with annual savings of $2 billion. Another one is Abbott Laboratories Inc. with total job cuts of...

  • BIG PHARMA'S SHRINKING PAINS.  // njbiz;12/8/2003, Vol. 16 Issue 49, p2 

    Reports on several pharmaceutical companies in New Jersey with retrenchment plans as of December 8, 2003. Schering-Plough in Kenilworth; Hoffman LaRoche in Nutley; Johnson & Johnson in North Brunswick.

  • MERCK & CO., INC.  // Contract Pharma;Jul/Aug2012, Vol. 14 Issue 6, p58 

    The article profiles Merck & Co. Inc. located in New Jersey, the number four company in the list of the top 20 pharma in the July/August 2012 issue of the journal "Contract Pharma." It says that a new wave of layoffs and shutdowns, following the 2009 restructuring that went down after the...

  • State Losing 2,500 Pharma, Health Care Jobs. P., Shankar // njbiz;7/14/2008, Vol. 21 Issue 29, p2 

    The article reports on job losses in pharmaceutical and health care companies in New Jersey in 2008 according to statistics from the state Department of Labor and Workforce Development. Pharmaceutical companies that will be losing jobs include Schering-Plough, Johnson & Johnson and Ortho Biotech...

  • Schering-Plough.  // Formulary;Oct2000 Resource Guide, Vol. 35 Issue 10, p92 

    Features the Schering-Plough, a pharmaceutical manufacturer. Focus of its research and development activities; Allocated budget for research and development of pharmaceutical products; Top antiviral agents; Drugs in late-stage development.

  • Schering CEO pessimistic about FDA woes.  // Medical Marketing & Media;Aug2001, Vol. 36 Issue 8, p30 

    Details the business planning of drug manufacturer Schering-Plough Corp. in the U.S. Effort of solving problems related to good manufacturing practices; Avoidance of litigation-attracting situations; Relations with the U.S. Food and Drug Administration.

  • DTC catapults Schering to top rank of growth companies. Seiden, Carl // Medical Marketing & Media;Dec99, Vol. 34 Issue 12, p82 

    Features United States pharmaceutical industry leader Schering-Plough Corp. Success of Schering's non-sedating antihistamine product Claritin; Financial performance for 1999; Strategy for promoting a hepatitis product; Lack of potential blockbusters in the long-term.

  • Schering-Plough's $12 million expansion nearly ready, local engineer Ileana Quinones at the helm. Ruano, Lida Estela // Caribbean Business;8/31/2000, Vol. 28 Issue 34, p17 

    Reports that Schering-Plough Products Inc.'s expansion of its manufacturing plant in Manati, Puerto Rico to facilitate local production of Albuterol, a drug for asthma, is in the final phase. Expected increase in the company's work from the addition of Albuterol; Appointment of Ileana Quinones...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics